ECI2 and nonpapillary renal cell carcinoma: Subsequently, we assessed the differential expression of ECI2 across ccRCC tumor cell lines, revealing significant reductions in the 786O and OS-RC-2 cell lines (Figures 6(d) and 6(e)).